Preferences for learning different types of genome sequencing results among young breast cancer patients: Role of psychological and clinical factors
- PMID: 29385583
- PMCID: PMC6065546
- DOI: 10.1093/tbm/ibx042
Preferences for learning different types of genome sequencing results among young breast cancer patients: Role of psychological and clinical factors
Abstract
The growing importance of genome sequencing means that patients will increasingly face decisions regarding what results they would like to learn. The present study examined psychological and clinical factors that might affect these preferences. 1,080 women diagnosed with breast cancer at age 40 or younger completed an online survey. We assessed their interest in learning various types of genome sequencing results: risk of preventable disease or unpreventable disease, cancer treatment response, uncertain meaning, risk to relatives' health, and ancestry/physical traits. Multivariable logistic regression was used to examine whether being "very" interested in each result type was associated with clinical factors: BRCA1/2 mutation status, prior genetic testing, family history of breast cancer, and psychological factors: cancer recurrence worry, genetic risk worry, future orientation, health information orientation, and genome sequencing knowledge. The proportion of respondents who were very interested in learning each type of result ranged from 16% to 77%. In all multivariable models, those who were very interested in learning a result type had significantly higher knowledge about sequencing benefits, greater genetic risks worry, and stronger health information orientation compared to those with less interest (p-values < .05). Our findings indicate that high interest in return of various types of genome sequencing results was more closely related to psychological factors. Shared decision-making approaches that increase knowledge about genome sequencing and incorporate patient preferences for health information and learning about genetic risks may help support patients' informed choices about learning different types of sequencing results.
Keywords: Breast cancer; Decision support; Genome sequencing; Genomic knowledge; Patient preferences; Return of results.
© Society of Behavioral Medicine 2018.
Figures
Comment in
-
Shared decision making: Implications for return of results from whole-exome and whole-genome sequencing.Transl Behav Med. 2018 Jan 29;8(1):80-84. doi: 10.1093/tbm/ibx048. Transl Behav Med. 2018. PMID: 29385585
Similar articles
-
Decision role preferences for return of results from genome sequencing amongst young breast cancer patients.Patient Educ Couns. 2019 Jan;102(1):155-161. doi: 10.1016/j.pec.2018.08.004. Epub 2018 Aug 4. Patient Educ Couns. 2019. PMID: 30098907 Free PMC article.
-
Information Topics of Greatest Interest for Return of Genome Sequencing Results among Women Diagnosed with Breast Cancer at a Young Age.J Genet Couns. 2017 Jun;26(3):511-521. doi: 10.1007/s10897-016-0006-2. Epub 2016 Aug 20. J Genet Couns. 2017. PMID: 27542972 Free PMC article.
-
Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.Oncol Nurs Forum. 2011 Sep;38(5):572-81. doi: 10.1188/11.ONF.572-581. Oncol Nurs Forum. 2011. PMID: 21875844
-
Decision making and decision support for hereditary breast-ovarian cancer susceptibility.Health Psychol. 2005 Jul;24(4S):S78-84. doi: 10.1037/0278-6133.24.4.S78. Health Psychol. 2005. PMID: 16045423 Review.
-
Parents' and patients' perspectives, experiences, and preferences for germline genetic or genomic testing of children with cancer: A systematic review.Genet Med. 2024 Sep;26(9):101197. doi: 10.1016/j.gim.2024.101197. Epub 2024 Jun 25. Genet Med. 2024. PMID: 38943478
Cited by
-
A primer in genomics for social and behavioral investigators.Transl Behav Med. 2020 May 20;10(2):451-456. doi: 10.1093/tbm/ibz018. Transl Behav Med. 2020. PMID: 30793199 Free PMC article.
-
Associations between subjective social status and predictors of interest in genetic testing among women diagnosed with breast cancer at a young age.Cancer Causes Control. 2024 Aug;35(8):1201-1212. doi: 10.1007/s10552-024-01878-0. Epub 2024 May 3. Cancer Causes Control. 2024. PMID: 38700724
-
Factors affecting breast cancer patients' need for genetic risk information: From information insufficiency to information need.J Genet Couns. 2019 Jun;28(3):543-557. doi: 10.1002/jgc4.1087. Epub 2019 Jan 24. J Genet Couns. 2019. PMID: 30675956 Free PMC article.
-
Interest in Cancer Predisposition Testing and Carrier Screening Offered as Part of Routine Healthcare Among an Ethnically Diverse Sample of Young Women.Front Genet. 2022 Apr 14;13:866062. doi: 10.3389/fgene.2022.866062. eCollection 2022. Front Genet. 2022. PMID: 35495140 Free PMC article.
-
In Different Voices: The Views of People with Disabilities about Return of Results from Precision Medicine Research.Public Health Genomics. 2020;23(1-2):42-53. doi: 10.1159/000506599. Epub 2020 Apr 15. Public Health Genomics. 2020. PMID: 32294660 Free PMC article.
References
-
- Mardis ER. The impact of next-generation sequencing technology on genetics. Trends Genet. 2008;24(3):133–141. - PubMed
-
- Biesecker LG, Green RC. Diagnostic clinical genome and exome sequencing. N Engl J Med. 2014;370(25):2418–2425. - PubMed
-
- Pasche B, Absher D. Whole-genome sequencing: a step closer to personalized medicine. JAMA. 2011;305(15):1596–1597. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous